FDA clears Siemens Opdima unit

Article

Siemens Medical Systems has received 510(k) clearance from the Food and Drug Administration for its Opdima digital spot mammography unit. Opdima is based on charge-coupled device (CCD) technology and retrofits to the Iselin, NJ, vendor's Mammomat 3000

Siemens Medical Systems has received 510(k) clearance from the Food and Drug Administration for its Opdima digital spot mammography unit. Opdima is based on charge-coupled device (CCD) technology and retrofits to the Iselin, NJ, vendor's Mammomat 3000 mammography system. It has a field-of-view of 49 x 85 mm, which Siemens claims is the largest in the industry among digital spot devices. Siemens launched Opdima in Europe in April (SCAN 4/30/97).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Diagnostic Imaging’s Top Five Breast Imaging Content: Summer 2025
Reducing Mammography Workload by Nearly 40 Percent? What a New Hybrid AI Study Reveals
 What New Research Reveals About Portable Low-Field MRI and Patients with Suspected Alzheimer’s Disease
© 2025 MJH Life Sciences

All rights reserved.